Canopy Growth Corporation (CGC)
Automate Your Wheel Strategy on CGC
With Tiblio's Option Bot, you can configure your own wheel strategy including CGC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CGC
- Rev/Share 1.0167
- Book/Share 2.6859
- PB 0.551
- Debt/Equity 0.3459
- CurrentRatio 5.4968
- ROIC -0.0826
- MktCap 354879333.0
- FreeCF/Share -0.3509
- PFCF -3.6912
- PE -1.0511
- Debt/Assets 0.238
- DivYield 0
- ROE -0.67
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CGC | The Benchmark Company | Sell | Hold | -- | -- | Nov. 10, 2025 |
News
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Published: December 22, 2025 by: MarijuanaStocks
Sentiment: Positive
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling fundamentally changes how the plant is viewed under federal law. With meaningful implications for operators, investors, and public markets. For the cannabis industry, the most immediate impact is financial. A shift to Schedule III would effectively eradicate IRS Section 280E. This is a law that currently prevents cannabis businesses from deducting standard operating expenses.
Read More
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
Published: December 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff highlights how fragile sentiment in cannabis stock remains, even amid policy progress. Further volatility is possible if regulatory implementation drags on or if broader market risk appetite weakens.
Read More
Trump signs executive order to reschedule cannabis. Here's what's next
Published: December 19, 2025 by: CNBC Television
Sentiment: Positive
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted the President's stance on the drug.
Read More
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
Published: December 19, 2025 by: New York Post
Sentiment: Positive
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government.
Read More
Trump Orders Marijuana Reclassification: What It Means for the Sector
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Trump's executive order to move marijuana to Schedule III could reshape cannabis regulation and taxes, lifting sentiment around cannabis stocks.
Read More
Trump sparks market shock with MAJOR marijuana move
Published: December 19, 2025 by: Fox Business
Sentiment: Negative
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's push to sell unused federal buildings.
Read More
Trump signs executive order to reschedule marijuana, expand access to CBD products
Published: December 18, 2025 by: Proactive Investors
Sentiment: Positive
President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is currently classified alongside heroin and LSD as a Schedule I drug — considered to have a high potential for abuse and no accepted medical use.
Read More
President Trump signs executive order to reclassify marijuana, easing federal restrictions
Published: December 18, 2025 by: CNBC Television
Sentiment: Positive
President Trump signs an executive order to reclassify marijuana to a Schedule III classification, easing federal restrictions.
Read More
Trump Signs Order Easing Federal Restrictions on Marijuana
Published: December 18, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how the worlds of money and politics intersect in the US capital: https://bloom.bg/3KkEimO -------- More on Bloomberg Television and Markets Like this video?
Read More
Trump signs executive order easing federal restrictions on marijuana
Published: December 18, 2025 by: Business Insider
Sentiment: Positive
Trump signed an executive order that will reclassify marijuana as a less harmful drug. The order is aimed at making it easier to research the drug.
Read More
Trump signs executive order reclassifying pot, opening door to broader access
Published: December 18, 2025 by: CNBC
Sentiment: Positive
President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.
Read More
Trump moves to ease cannabis restrictions - what does it mean for consumers?
Published: December 18, 2025 by: Reuters
Sentiment: Positive
U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here's a look at what that would mean for people shopping at dispensaries across the country.
Read More
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Published: December 18, 2025 by: Reuters
Sentiment: Positive
Shares of cannabis firms rose in premarket trading on Thursday, driven by expectations that U.S. President Donald Trump will sign an executive order easing federal regulations on marijuana.
Read More
Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?
Published: December 17, 2025 by: Fast Company
Sentiment: Positive
Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana.
Read More
Canopy Growth to acquire MTL Cannabis, expanding Québec presence
Published: December 16, 2025 by: Proactive Investors
Sentiment: Positive
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) announced that it has agreed to acquire MTL Cannabis (CSE:MTLC) in a transaction valued at approximately C$125 million on a fully diluted equity basis and about C$179 million on an enterprise value basis. Under the terms of a definitive arrangement agreement, Canopy Growth will acquire all issued and outstanding shares of MTL Cannabis and settle the target's outstanding debt and debt-like instruments.
Read More
Best Canadian Cannabis Stocks to Watch This Week for Traders and Investors
Published: December 16, 2025 by: MarijuanaStocks
Sentiment: Positive
Canadian cannabis stocks remain in focus this week as sector sentiment continues improving. Several Canadian operators maintain meaningful exposure to the U.S. market through brands and partnerships. Meanwhile, the U.S. cannabis industry continues expanding despite regulatory delays. Total U.S. cannabis sales now exceed $32 billion annually. Importantly, analysts project the market could surpass $50 billion by 2030. That growth outlook keeps Canadian operators relevant for global investors. Recently, renewed federal reform discussions returned to headlines. Cannabis rescheduling remains under active government review. Additionally, lawmakers continue debating banking access and tax reform measures. While timing remains uncertain, momentum has improved compared …
Read More
The Rally for Cannabis Stocks Grinds to a Halt Amid Uncertainty About Trump Order
Published: December 15, 2025 by: Investopedia
Sentiment: Negative
Weed stocks aren't flying so high anymore.
Read More
Trump Expected to Label Pot a Less Dangerous Drug
Published: December 12, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks.
Read More
Trump Lights Up the Cannabis Market With Plans for Reclassification
Published: December 12, 2025 by: 24/7 Wall Street
Sentiment: Positive
Trump plans to sign an executive order directing federal agencies to reclassify marijuana from Schedule I to Schedule III. Reclassification could boost after-tax profits by 40% to 70% for U.S. cannabis operators by ending the 280E tax penalty.
Read More
Marijuana Stocks Are Soaring Friday on Anticipation Trump Could Soon Make This Change
Published: December 12, 2025 by: Investopedia
Sentiment: Positive
Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance.
Read More
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Published: December 12, 2025 by: CNBC Television
Sentiment: Positive
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.
Read More
Cannabis stocks rise on reports Trump may reschedule marijuana
Published: December 12, 2025 by: Proactive Investors
Sentiment: Positive
Cannabis stocks surged on Friday on reports that President Donald Trump is considering an executive order to reschedule marijuana at the federal level, potentially moving it from Schedule I to Schedule III. According to people familiar with the matter, Trump has discussed the proposal with marijuana industry executives, Health and Human Services Secretary Robert F.
Read More
Tilray and Canopy Growth Stocks Surge on Reports Trump to Loosen Marijuana Restrictions
Published: December 12, 2025 by: Barrons
Sentiment: Positive
The reclassification of the drug would alleviate tax burdens on cannabis companies.
Read More
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Published: December 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
Read More
'Green Wednesday': A high holiday for cannabis before Thanksgiving
Published: November 26, 2025 by: CNBC Television
Sentiment: Positive
Cannabis has carved out it's own holiday shopping rush and it's called "Green Wednesday". Behind April 20, the day before Thanksgiving has become the second-biggest day for cannabis sales in the U.S. Brandon Gomez unpacks the new buzzy trend for an age old tradition.
Read More
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Three Canadian Cannabis Stocks Worth Watching This Week
Published: November 18, 2025 by: MarijuanaStocks
Sentiment: Positive
The U.S. legal cannabis industry is showing strong momentum, and the time may be ripe to scan for promising Canadian-listed stocks. In fact, the U.S. market is projected to reach about US$45 billion in 2025, growing at roughly an 11-12 percent annual rate through the rest of the decade. Meanwhile, public support for reform sits near record levels, and recent headlines highlighted renewed federal attention on descheduling efforts. These developments increased optimism, although uncertainty remains. Consequently, Canadian cannabis companies with U.S. exposure could benefit significantly if policy improves. At the same time, traders should not overlook technical analysis. Reviewing chart …
Read More
Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels
Published: November 18, 2025 by: Business Wire
Sentiment: Neutral
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company's medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis.
Read More
Should You Buy, Hold or Sell CGC Stock Post Q2 Earnings Release?
Published: November 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.
Read More
About Canopy Growth Corporation (CGC)
- IPO Date 2014-04-07
- Website https://www.canopygrowth.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Luc Mongeau
- Employees 1029